Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-09-26

Rui Zhang

Role not yet determined Is this you? Add your title

2 pubs

  • Immune Checkpoint Inhibitors
  • Antineoplastic Combined Chemotherapy Protocols
  • Esophageal Neoplasms
  • Esophagogastric Junction
  • Stomach Neoplasms
  • Pathologic Complete Response
  • Humans
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Perioperative Care

Biography and Research Information

OverviewAI-generated summary

Rui Zhang's research focuses on meta-analyses of randomized controlled trials, specifically investigating the efficacy and safety of traction-assisted endoscopic submucosal dissection for superficial gastric neoplasms. This work contributes to understanding treatment outcomes in gastrointestinal oncology. Zhang has one publication, a 2026 meta-analysis, and has collaborated with Jing Xie at the University of Arkansas for Medical Sciences on shared publications, indicating an active research network within the institution.

Metrics

  • Publications: 2

Selected Publications

  • Perioperative immunochemotherapy for resectable gastric or gastroesophageal junction cancer: a meta-analysis of efficacy and safety from randomized trials (2026)
    Frontiers in Immunology DOI OpenAlex
  • Efficacy and safety of traction-assisted endoscopic submucosal dissection for superficial gastric neoplasms: a meta-analysis of randomized controlled trials (2026)
    Frontiers in Oncology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

9 Collaborators 5 Institutions 3 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics